IRDAI Warns Niva Bupa Health Insurance Over Expenses Breach, Bars New Branches for 6 Months
Niva Bupa Health Insurance: The regulator’s action puts the spotlight on Niva Bupa’s expense management and compliance practices. The six-month branch restriction could also affect the insurer’s physical expansion plans.
IRDAI has taken regulatory action against Niva Bupa Health Insurance over an alleged breach related to expense limits, including a six-month restriction on opening new branches.
Niva Bupa Health Insurance: IRDAI issues warning to listed health insurer Niva Bupa for non-compliance with Expenses of Management norms for FY 2024-25; company barred from opening new places of business until February 2027
New Delhi: India’s regulator the Insurance Regulatory and Development Authority of India (IRDAI) has issued a warning to Niva Bupa Health Insurance Company Limited for failing to comply with applicable Expenses of Management (EoM) limits for the financial year 2024-25, according to a regulatory disclosure filed by the company on Thursday.
Along with the warning, the regulator has directed the company not to open any new place of business for a period of six months from the date of the order, meaning the restriction will remain in effect until approximately February 19, 2027.
Also Read: Tamil Nadu Health Insurance: Govt To Launch Plans For Elderly. All You Need To Know
The disclosure states that IRDAI had earlier sought an explanation from Niva Bupa on its EoM limits for FY 2024-25, to which the company had made submissions before the order was passed.
IRDAI passed the order on August 19, 2026, at 1808 hours IST, according to the disclosure filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
According to the disclosure, the violation pertains to non-compliance with Regulation 6 read with Regulations 10, 11 and 19 of the IRDAI (Expenses of Management, including Commission of Insurers) Regulations, 2024.
The company stated that the impact of the order on its financial, operational or other activities is “Nil,” and described the expected financial implications as “None.”
In its filing, Niva Bupa said it is “evaluating the order and will take appropriate steps to safeguard the interest of stakeholders.”
The company further stated that it is in compliance with the IRDAI (Expenses of Management, including Commission of Insurers) Regulations, 2024 for the full financial year ended March 31, 2026, as well as for the quarter ended June 30, 2026, and said it is on track to ensure compliance with the regulations for the full financial year ending March 31, 2027.
Niva Bupa Health Insurance: What is Expenses of Management (EoM)? How IRDAI is changing that:
Niva Bupa Health Insurance: The Niva Bupa action comes against the backdrop of a broader rethink of how insurers manage distribution costs. Under IRDAI’s current Expenses of Management (EoM) framework, commissions paid to agents and other intermediaries form part of the overall expenses that insurers have to keep within prescribed limits. The framework moved away from the earlier product-wise commission caps, giving insurers greater flexibility to determine payouts through board-approved policies, but with an overall ceiling on expenses.
IRDAI is now examining a further overhaul of the commission structure, with an effort-based model among the proposals being discussed. The idea is to link remuneration more closely to the actual work involved in selling and servicing a policy, rather than simply the premium or product sold. The regulator is also examining staggered or deferred commission payouts, which could spread remuneration over the policy term instead of paying a large portion upfront. The broader objective is to better align distributor incentives with policyholder interests and address concerns around mis-selling, churn and rising distribution costs.
In that context, the Niva Bupa order is significant because it shows that EoM compliance is not merely an accounting exercise. IRDAI has now demonstrated that exceeding the prescribed limits can have consequences for an insurer’s expansion plans. The regulator has warned Niva Bupa for non-compliance in FY2024-25 and barred it from opening new places of business for six months from August 19, 2026. Niva Bupa has, however, said that it was compliant with the EoM regulations in FY2025-26 and the April-June 2026 quarter, and remains compliant for FY2026-27.
